Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K212824
    Date Cleared
    2022-02-17

    (167 days)

    Product Code
    Regulation Number
    880.6500
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Bluezone Model RX-450 Air Purifier is a free standing, air purifying device utilizing germicidal ultraviolet light (UV-C wavelengths near 254nm) intended for inactivation of indoor airborne aerosols including bacteria, mold, and virus in medical facilities and occupied spaces.

    The Bluezone Model Rx-450 Air Purifier has been demonstrated to entrain and destroy the following exposure/working conditions:

    Test ItemAverage Net Log Reduction/Time @ High FanSpeed. Room Temperature Test
    BacteriaBacillus atrophaeus4.95 / 60 minutes
    BacteriaBacillus atrophaeus4.00 / 48 minutes
    MoldPenicillium rocqueforti4.40 / 60 minutes
    MoldPenicillium rocqueforti4.00 / 52 minutes
    VirusMS-2 bacteriophage5.32 / 60 minutes
    VirusMS-2 bacteriophage4.00 / 40 minutes
    Device Description

    The Bluezone Model RX-450 is an air purification device that uses germicidal UV bulbs to inactivate viral, bacterial or fungal aerosols. The operation of the device is as follows: ambient air containing microbial aerosols is drawn into the air purifier through a prefilter and two angled aluminum honeycomb light baffles. The infective aerosols in the air are then exposed to high intensity, germicidal, ultraviolet light where the contaminants receive a UV dose of at least 10 mW*second/cm². The bacterial, fungal and viral aerosols are inactivated through the breakdown of the microbial DNA or RNA. The cleaned air is exhausted back into the room from the Bluezone Model RX-450 through an axial fan.

    AI/ML Overview

    The provided text describes the regulatory filing for the "Bluezone Model RX-450 Air Purifier." This device is an air purifier that uses UV-C light to inactivate airborne bacteria, mold, and viruses. The document details the device's technical specifications, indications for use, and the non-clinical testing performed to establish its performance and safety.

    Here's the breakdown of the acceptance criteria and the study proving the device meets them, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    Test CompletedAcceptance CriteriaReported Device Performance
    Electrical SafetyPer UL 507: 2017 Ed. 10+R: 06Nov2018 Fans and Ventilators; CSA C22.2#113:2018 Ed. 11Passed
    Electromagnetic CompatibilityPer IEC 60601-1-2:2014 (4th Edition) General Requirements for Safety- Collateral Electromagnetic Compatibility Requirements and Tests Medical Electrical EquipmentPassed
    Safety of air-cleaning appliancesPer IEC 60335-2-65 Safety of household and similar electrical appliances Part 2: Particular requirements for air-cleaning appliancesTest specifications were met
    Ozone Emissions Testing of Household Electrostatic Air CleanersEmittance of ozone not exceeding a concentration of 0.050 ppm (UL 867 Section 40, Fifth Edition; CSA 22-2 No. 187-15, Section 7)Found in compliance with criteria
    Zero Ozone EmissionOzone < 0.005 ppm (UL 2998 Section 6)Passed. Ozone < 0.001 ppm
    UV Irradiance and Leakage in Occupied SpacesEffective irradiance < 0.1 uW/cm² (UL 507-2017: Heating and Cooling Equipment)Passed. Location 1 Effective irradiance 6.55E-02 uW/cm² and Location 2 3.13E-03 uW/cm²
    Removal of Aerosolized MS2 Bacteriophage4.0 net LOG reductionProduced a rapid reduction in viable MS2 within the 60-minute test period. The Bluezone RX-450 is estimated to reach a 4.0 net LOG reduction of viable MS2 bioaerosol in a 16m³ chamber at 35 minutes.
    Removal of Bacterial Spores (Bacillus atrophaeus)99.99% reduction in active aerosolized bacterial sporesAchieved 99.99% reduction in active aerosolized bacterial spores in less than 48 minutes in a 735 cubic foot test chamber.
    Removal of Mold Spores (Penicillium rocqueforti)99.99% reduction in active aerosolized moldsAchieved 99.99% reduction in active aerosolized molds in less than 1 hour in a 735 cubic foot test chamber.

    Additionally, the "Indications for Use" section (pages 2 and 4) provides specific performance targets for different microorganisms, which can also be considered acceptance criteria.

    Test ItemAcceptance Criteria (Average Net Log Reduction/Time @ High Fan Speed. Room Temperature Test)Reported Device Performance
    Bacteria (Bacillus atrophaeus)4.95 / 60 minutesAchieved 99.99% reduction (equivalent to ~4.0 log reduction) in less than 48 minutes.
    Bacteria (Bacillus atrophaeus)4.00 / 48 minutesAchieved 99.99% reduction (equivalent to ~4.0 log reduction) in less than 48 minutes.
    Mold (Penicillium rocqueforti)4.40 / 60 minutesAchieved 99.99% reduction (equivalent to ~4.0 log reduction) in less than 1 hour.
    Mold (Penicillium rocqueforti)4.00 / 52 minutesAchieved 99.99% reduction (equivalent to ~4.0 log reduction) in less than 1 hour.
    Virus (MS-2 bacteriophage)5.32 / 60 minutesReached a 4.0 net LOG reduction in 35 minutes (in 16m³ chamber).
    Virus (MS-2 bacteriophage)4.00 / 40 minutesReached a 4.0 net LOG reduction in 35 minutes (in 16m³ chamber).

    Note: 99.99% reduction is equivalent to a 4.0 log reduction.

    2. Sample Size Used for the Test Set and Data Provenance

    The document describes non-clinical laboratory testing rather than human subject or image-based studies. Therefore, typical "sample sizes" for test sets in the context of AI/machine learning or human reader studies are not applicable directly.

    • Sample Size: The data for the efficacy tests (microorganism removal) are based on controlled laboratory experiments using specific volumes (e.g., 16m³ chamber for MS2, 735 cubic foot chamber for bacterial/mold spores). The precise number of replicate tests or experimental runs is not specified in this summary document.
    • Data Provenance: The tests are described as non-clinical testing, implying lab-based experiments. No information is provided regarding the country of origin of the data collectors/labs, nor is it specified if the data is retrospective or prospective, as these terms typically apply to clinical studies. Given it's a device efficacy test, it would inherently be prospective.

    3. Number of Experts Used to Establish Ground Truth and Qualifications

    • Not Applicable: This filing describes physical device performance testing (e.g., electrical safety, UV irradiance, germicidal efficacy against lab-cultured microorganisms), not AI/machine learning performance requiring human expert ground truth labeling. Therefore, there is no mention of experts establishing ground truth in this context.

    4. Adjudication Method for the Test Set

    • Not Applicable: As this is non-clinical device performance testing, adjudication methods typically used for human expert review in diagnostic studies are not relevant. The results are obtained from direct measurements and observations in a laboratory setting.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • Not Applicable: The document explicitly states "Summary of Clinical Testing: Not applicable." This is a premarket notification (510(k)) for an air purification device, and its safety and efficacy were demonstrated through non-clinical laboratory tests, not comparative human clinical trials or diagnostic performance studies involving human readers.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance)

    • Not Applicable: This is a physical device (air purifier), not a software algorithm or AI. Its performance is inherent to its design and function.

    7. Type of Ground Truth Used

    The ground truth for this device's performance is established through laboratory measurements and direct observation of microbial inactivation.

    • Microorganism Inactivation: The ground truth for efficacy (e.g., log reduction of bacteria, mold, virus) is determined by standard microbiological testing methods, likely involving quantifying viable microorganisms before and after exposure to the device in a controlled chamber. This is analogous to outcomes data in a very specific, controlled laboratory environment.
    • Safety Parameters: Ground truth for electrical safety, ozone emission, and UV leakage are based on adherence to recognized safety standards (e.g., UL, IEC) through direct measurement by specialized equipment.

    8. Sample Size for the Training Set

    • Not Applicable: This is a physical device, and the concept of a "training set" (used for machine learning models) does not apply here. The device's design and operating parameters are not "trained" on data in the same way an algorithm would be. Its performance is a result of its engineering.

    9. How the Ground Truth for the Training Set Was Established

    • Not Applicable: As there is no "training set" for a physical device, the method of establishing ground truth for it is not relevant. The device is built based on established principles of UV-C germicidal action, and its performance is
      verified through empirical testing as detailed above.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1